WORK Medical Technology Group LTD - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K report, filed on August 14, 2026, covers material events for WORK Medical Technology Group LTD, a Cayman Islands exempted company. The filing details a proposed private placement of equity securities and the recent completion of a share consolidation to maintain Nasdaq listing compliance.
Key Financial Metrics and Capital Structure
- Proposed Capital Raise: The Company entered into agreements to sell 2,000,000 Class A ordinary shares at $1.00 per share and 50,000 Class B ordinary shares at $2.50 per share.
- Expected Proceeds: Approximately $2,125,000, intended for business expansion, working capital, and general corporate purposes.
- Transaction Status: As of the filing date, closing conditions have not been satisfied, and no shares have been issued.
- Share Consolidation: Effective June 18, 2026, the Company executed a 100-for-1 reverse stock split. Post-consolidation, approximately 2,417,548 ordinary shares were outstanding (2,416,539 Class A and 1,009 Class B).
- Financial Performance: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Share Consolidation: Implemented to meet Nasdaq Listing Rule 5550(a)(2) regarding minimum bid price and to mitigate delisting risk. The par value per share increased from US$0.00001 to US$0.001.
- Capitalization Adjustment: Authorized share capital was amended to 160,000,000 Class A and 40,000,000 Class B ordinary shares following the consolidation.
- Corporate Governance: The Amended and Restated Memorandum of Association became effective on May 14, 2026.
Outlook, Risks, and Contingencies
- Private Placement Contingency: The issuance of new shares is subject to customary closing conditions and reliance on Section 4(a)(2) and Regulation S exemptions. No general solicitation was used.
- Transfer Restrictions: New shares will be subject to transfer restrictions and legends indicating they are unregistered under the Securities Act of 1933.
- Forward-Looking Statements: The report includes standard disclaimers regarding risks, uncertainties, and the competitive environment that could cause actual results to differ from expectations.
Investor Verification Checklist
- Verify the satisfaction of closing conditions for the $2,125,000 private placement.
- Confirm the current trading status and bid price of shares on Nasdaq under symbol "WOK" (CUSIP: G9767H133) post-consolidation.
- Review the full text of the Securities Purchase Agreements (Exhibits 10.1 and 10.2) for specific investor terms.
- Check subsequent filings for updates on the use of proceeds and any changes to the capital structure.